Company allegedly received £7 bn bid from US rival Johnson & Johnson in weeks before Christmas
| Tweet |
Smith & Nephew, the UK-based medical-device maker, has remained silent this morning despite a sharp rise in its share price following speculation of a possible bid.
The company’s shares have risen more than 10 percent in London after a Sky News report published over the weekend said Smith & Nephew rejected ...
Register now to read the rest of this article! Registration is free and you will be able to read five articles every month.
Become a subscriber for unlimited access.
Ipreo: Global Equity Assets Report - Q4 2011
Dix & Eaton: Are you ready for the public?